| Scorecard |
|---|
|
---
|
|
Lipper
---
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
---
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 1.21 | 0.03 | 1.17 |
| Stocks | 44.11 | 0.0 | 44.11 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 1.22 | 0.0 | 1.22 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 53.5 | 0.0 | 53.5 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Royal Dutch Shell PLC Class A | RYDAF | -0.16 | 0.86 |
| AstraZeneca PLC | AZN | --- | 0.8 |
| HSBC Holdings PLC | HBCYF | 4.07 | 0.8 |
| Baxter International Inc. | BAX | 4.05 | 0.76 |
| Apple Inc | AAPL | -16.96 | 0.72 |
| Johnson & Johnson | JNJ | 21.03 | 0.71 |
| AbbVie Inc | ABBV | 35.69 | 0.7 |
| Microsoft Corporation | MSFT | 23.36 | 0.7 |
| Eli Lilly and Company | LLY | 10.97 | 0.68 |
| Colgate-Palmolive Company | CL | 15.21 | 0.65 |
